Clinical trial
Duloxetine for the Treatment of Dysthymia
NCT00185575 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00185575 |
|---|---|
| Title | Duloxetine for the Treatment of Dysthymia |
| Official title | Duloxetine for the Treatment of Dysthymia |
| Lead sponsor | Stanford University, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | duloxetine |
| Enrollment | 24 |
| Start date | Sep 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 9, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: